NHS vs. CCLFX
NHS (Neuberger Berman High Yield Strategies Fund) and CCLFX (Cliffwater Corporate Lending Fund) are both High Yield Bonds funds. Over the past 5 years, NHS returned -1.23%/yr vs 8.75%/yr for CCLFX. At a 0.12 correlation, their price movements are largely independent. NHS charges 4.14%/yr vs 3.42%/yr for CCLFX.
Performance
NHS vs. CCLFX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NHS achieves a -8.61% return, which is significantly lower than CCLFX's 2.33% return.
NHS
- 1D
- -0.78%
- 1M
- -0.77%
- YTD
- -8.61%
- 6M
- -5.44%
- 1Y
- -1.69%
- 3Y*
- 8.23%
- 5Y*
- -1.23%
- 10Y*
- 5.71%
CCLFX
- 1D
- 0.10%
- 1M
- 0.48%
- YTD
- 2.33%
- 6M
- 2.93%
- 1Y
- 7.37%
- 3Y*
- 10.57%
- 5Y*
- 8.75%
- 10Y*
- —
NHS vs. CCLFX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NHS Neuberger Berman High Yield Strategies Fund | -8.61% | 14.81% | 11.04% | 6.12% | -22.99% | 15.78% | 4.57% | 12.78% |
CCLFX Cliffwater Corporate Lending Fund | 2.33% | 8.93% | 12.62% | 12.66% | 2.32% | 10.38% | 8.73% | 2.12% |
Correlation
The correlation between NHS and CCLFX is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Jun 6, 2019 | 0.12 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NHS vs. CCLFX — Risk / Return Rank
NHS
CCLFX
NHS vs. CCLFX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Neuberger Berman High Yield Strategies Fund (NHS) and Cliffwater Corporate Lending Fund (CCLFX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NHS | CCLFX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -8.63 | ||
| Sortino ratioReturn per unit of downside risk | -20.21 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 7.24 | -6.25 |
| Calmar ratioReturn relative to maximum drawdown | -0.10 | 39.22 | -39.32 |
| Martin ratioReturn relative to average drawdown | -0.25 | 215.60 | -215.85 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NHS | CCLFX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.13 | 8.50 | -8.63 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.08 | 5.10 | -5.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.34 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 4.57 | -4.22 |
Drawdowns
NHS vs. CCLFX - Drawdown Comparison
The maximum NHS drawdown since its inception was -64.67%, which is greater than CCLFX's maximum drawdown of -3.91%. Use the drawdown chart below to compare losses from any high point for NHS and CCLFX.
Loading charts...
Drawdown Indicators
| NHS | CCLFX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.67% | -3.91% | -60.76% |
Max Drawdown (1Y)Largest decline over 1 year | -17.01% | -0.19% | -16.82% |
Max Drawdown (3Y)Largest decline over 3 years | -17.01% | -0.46% | -16.55% |
Max Drawdown (5Y)Largest decline over 5 years | -37.43% | -2.25% | -35.18% |
Max Drawdown (10Y)Largest decline over 10 years | -42.97% | — | — |
Current DrawdownCurrent decline from peak | -14.13% | 0.00% | -14.13% |
Average DrawdownAverage peak-to-trough decline | -8.86% | -0.16% | -8.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.80% | 0.03% | +6.77% |
Volatility
NHS vs. CCLFX - Volatility Comparison
Neuberger Berman High Yield Strategies Fund (NHS) has a higher volatility of 3.01% compared to Cliffwater Corporate Lending Fund (CCLFX) at 0.25%. This indicates that NHS's price experiences larger fluctuations and is considered to be riskier than CCLFX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NHS | CCLFX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.01% | 0.25% | +2.76% |
Volatility (6M)Calculated over the trailing 6-month period | 9.91% | 0.65% | +9.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 12.87% | 0.88% | +11.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.16% | 1.73% | +14.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.70% | 1.88% | +14.82% |
NHS vs. CCLFX - Expense Ratio Comparison
NHS has a 4.14% expense ratio, which is higher than CCLFX's 3.42% expense ratio.
Dividends
NHS vs. CCLFX - Dividend Comparison
NHS's dividend yield for the trailing twelve months is around 17.06%, more than CCLFX's 10.28% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CCLFX Cliffwater Corporate Lending Fund | 10.28% | 10.47% | 11.27% | 10.96% | 3.96% | 7.03% | 6.90% | 0.61% | 0.00% | 0.00% | 0.00% | 0.00% |
NHS Neuberger Berman High Yield Strategies Fund | 17.06% | 14.60% | 14.50% | 13.94% | 12.75% | 8.74% | 9.29% | 7.99% | 8.37% | 7.59% | 8.23% | 9.81% |
Frequently Asked Questions
NHS and CCLFX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NHS has higher volatility (3.01%) compared to CCLFX (0.25%). In terms of maximum drawdown, NHS dropped -64.67% vs CCLFX's -3.91%.
CCLFX currently has the higher Sharpe Ratio (8.50 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NHS and CCLFX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer